Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene McFadden

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Circulation|July 16, 2003
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of casesPedro A Lemos, Francesco Saia, Jurgen M R Ligthart, et al.
Journal of the American College of Cardiology|February 28, 2015
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidatesMarco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
Circulation|December 24, 2003
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Patrick W Serruys, Ron T van Domburg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Quantification of scientific output in cardiovascular medicine: a perspective based on global dataGastón A Rodriguez-Granillo, Alfredo E Rodriguez, Nico Bruining, et al.
American Heart Journal|August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCIRaffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
The International Journal of Cardiovascular Imaging|July 28, 2005
Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biologyCarlos A G Van Mieghem, Nico Bruining, Johannes A Schaar, et al.
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
International Journal of Cardiology|September 27, 2025
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical backgroundErnest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, et al.
Journal of the American College of Cardiology|September 2, 2025
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized TrialRaffaele Piccolo, Paolo Calabrò, Greta Carrara, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Circulation|July 16, 2003
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of casesPedro A Lemos, Francesco Saia, Jurgen M R Ligthart, et al.
Journal of the American College of Cardiology|February 28, 2015
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidatesMarco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
Circulation|December 24, 2003
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Patrick W Serruys, Ron T van Domburg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Quantification of scientific output in cardiovascular medicine: a perspective based on global dataGastón A Rodriguez-Granillo, Alfredo E Rodriguez, Nico Bruining, et al.
American Heart Journal|August 12, 2023
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCIRaffaele Piccolo, Paolo Calabrò, Attilio Varricchio, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
The International Journal of Cardiovascular Imaging|July 28, 2005
Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biologyCarlos A G Van Mieghem, Nico Bruining, Johannes A Schaar, et al.
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
International Journal of Cardiology|September 27, 2025
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical backgroundErnest Spitzer, Francesco Costa, Ingibjörg Jóna Guðmundsdóttir, et al.
Journal of the American College of Cardiology|September 2, 2025
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized TrialRaffaele Piccolo, Paolo Calabrò, Greta Carrara, et al.
Pageof 7